REG - Citadel Group Mural Oncology PLC - Form 8.3 - Mural Oncology plc

Mural OncologyAnnouncement

13/08/2025 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250813:nRSM2163Va&default-theme=true

RNS Number : 2163V  Citadel Group  13 August 2025

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH
TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE

 

1.             KEY INFORMATION

 

 (a)   Full name of discloser                                                     Citadel Group
 (b)   Owner or controller of interests and short positions disclosed, if         N/A
 different from 1(a)

 The naming of nominee or vehicle companies is insufficient. For a trust, the
 trustee(s), settlor and beneficiaries must be named.
 (c)   Name of offeror/offeree in relation to whose relevant securities this      MURAL ONCOLOGY PLC
 form relates

 Use a separate form for each offeror/offeree
 (d)   If an exempt fund manager connected with an offeror/offeree, state         N/A
 this and specify identity of offeror/offeree (Note 1)
 (e)   Date position held/dealing undertaken                                      12 August 2025

 For an opening position disclosure, state the latest practicable date prior to
 the disclosure
 (f)    In addition to the company in 1(c) above, is the discloser also           N/A
 making disclosures in respect of any other party to the offer?

 If it is a cash offer or possible cash offer, state "N/A"

 

2.             INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class
of relevant securities of the offeror or offeree named in 1(c), copy table 2
for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or
offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

 

 Class of relevant security                                               Common Stock ISIN IE000LK2BOB4
 (Note 3)

                                                                          $0.01 ordinary shares
                                                                          Interests           Short positions
                                                                          Number    %         Number    %
 (1)   Relevant securities owned and/or controlled                        192,504   1.11      0         0.00
 (2)   Cash-settled derivatives                                           0         0.00      23        0.00
 (3)   Stock-settled derivatives (including options) and agreements to    38,100    0.21      133,200   0.76
 purchase/ sell
 Total                                                                    230,604   1.33      133,223   0.76

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any
open stock-settled derivative positions (including traded options), or
agreements to purchase or sell relevant securities, should be given on a
Supplemental Form 8.

 

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE
DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities
of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)           Purchases and sales

 

 Class of relevant  Purchase/sale     Number of    Price per unit

security
securities  (Note 5)
  Common            Buy Transaction   2,903        1.5600 USD
  Common            Buy Transaction   554          1.5609 USD
  Common            Buy Transaction   2,657        1.5625 USD
  Common            Buy Transaction   100          1.5700 USD
  Common            Buy Transaction   200          1.5708 USD
  Common            Buy Transaction   1,603        1.5729 USD
  Common            Buy Transaction   114          1.5800 USD
  Common            Buy Transaction   100          1.5950 USD
  Common            Buy Transaction   1,856        1.6000 USD
  Common            Buy Transaction   623          1.6065 USD
  Common            Buy Transaction   425          1.6100 USD
  Common            Buy Transaction   417          1.6276 USD
  Common            Buy Transaction   200          1.6300 USD
  Common            Buy Transaction   36,300       1.6417 USD
  Common            Buy Transaction   5,209        1.6444 USD
  Common            Buy Transaction   1,200        1.6483 USD
  Common            Buy Transaction   3,362        1.6500 USD
  Common            Buy Transaction   6,432        1.6538 USD
  Common            Buy Transaction   115          1.6587 USD
  Common            Buy Transaction   185          1.6600 USD
  Common            Buy Transaction   40           1.6603 USD
  Common            Buy Transaction   1,100        1.6604 USD
  Common            Buy Transaction   4,501        1.6700 USD
  Common            Buy Transaction   2,500        1.6701 USD
  Common            Buy Transaction   13,900       1.6725 USD
  Common            Buy Transaction   677          1.6771 USD
  Common            Buy Transaction   17,100       1.6779 USD
  Common            Buy Transaction   1,751        1.6826 USD
  Common            Buy Transaction   14,483       1.6900 USD
  Common            Buy Transaction   99           1.7100 USD
  Common            Sell Transaction  31           1.5700 USD
  Common            Sell Transaction  1,603        1.5729 USD
  Common            Sell Transaction  1            1.5900 USD
  Common            Sell Transaction  425          1.6100 USD
  Common            Sell Transaction  690          1.6176 USD
  Common            Sell Transaction  1            1.6400 USD
  Common            Sell Transaction  982          1.6482 USD
  Common            Sell Transaction  3,703        1.6500 USD
  Common            Sell Transaction  17           1.6524 USD
  Common            Sell Transaction  179          1.6600 USD
  Common            Sell Transaction  4,020        1.6601 USD
  Common            Sell Transaction  246          1.6627 USD
  Common            Sell Transaction  32,628       1.6629 USD
  Common            Sell Transaction  100          1.6650 USD
  Common            Sell Transaction  2,500        1.6700 USD
  Common            Sell Transaction  1            1.6712 USD
  Common            Sell Transaction  5            1.6800 USD
  Common            Sell Transaction  166          1.6840 USD
  Common            Sell Transaction  21,323       1.6846 USD
  Common            Sell Transaction  218          1.6854 USD
  Common            Sell Transaction  23,886       1.6864 USD
  Common            Sell Transaction  215          1.6900 USD
  Common            Sell Transaction  55           1.7038 USD
  Common            Sell Transaction  60           1.7500 USD

 

Ap29

 

(b)           Cash-settled derivative transactions

 

 Class of   Product        Nature of dealing                                                            Number of     Price
 relevant   description    e.g. opening/ closing a long/ short position, increasing/ reducing a long/   reference     per unit
 security   e.g. CFD       short position                                                               securities    (Note 5)
                                                                                                        (Note 6)

 

(c)           Stock-settled derivative transactions (including
options)

 

(i)            Writing, selling, purchasing or varying

 

 Class of    Product                  Writing, purchasing, selling, varying   Number        Exercise     Type         Expiry      Option
 relevant    description e.g. call    etc.                                    of
price per   e.g.         date        money
 security    option                                                           securities    unit         American,
paid/
                                                                              to which                   European                 received per unit
                                                                              option
etc.
                                                                              relates
                                                                              (Note 6)
 Common      Call Option              Sell Transaction                        1,500         5.0000 USD   American     2027-01-15  0.0100 USD
 Common      Call Option              Sell Transaction                        400           2.5000 USD   American     2025-12-19  0.0300 USD

 

(ii)           Exercise

 

 Class of    Product        Exercising/   Number of    Exercise
 relevant    description    exercised     securities   price per
 security    e.g. call      against                    unit
             option                                    (Note 5)

 

(d)           Other dealings (including transactions in respect of
new securities) (Note 3)

 

 Class of    Nature of dealing      Details  Price per unit (if
 relevant    e.g. subscription,              applicable)
 security    conversion, exercise            (Note 5)

 

Ap30

 

4.             OTHER INFORMATION

 

(a)           Indemnity and other dealing arrangements

 

 Details of any indemnity or option arrangement, or any agreement or
 understanding, formal or informal, relating to relevant securities which may
 be an inducement to deal or refrain from dealing entered into by the person
 making the disclosure and any party to the offer or any person acting in
 concert with a party to the offer.

 Irrevocable commitments and letters of intent should not be included. If there
 are no such agreements, arrangements or understandings, state "none"
  None

 

(b)           Agreements, arrangements or understandings relating to
options or derivatives

 

 Full details of any agreement, arrangement or understanding between the person
 disclosing and any other person relating to the voting rights of any relevant
 securities under any option referred to on this form or relating to the voting
 rights or future acquisition or disposal of any relevant securities to which
 any derivative referred to on this form is referenced. If none, this should be
 stated.
  None

 

(c)           Attachments

 

 Is a Supplemental Form 8 attached?  YES

 

 Date of disclosure  13 August 2025
 Contact name        Paula Santos
 Telephone number    020 7645 9700

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory
Information Service.

 

 

 

Ap32

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

 

1.             KEY INFORMATION

 

 Full name of person making            Citadel Group
 disclosure:
 Name of offeror/offeree in relation   MURAL ONCOLOGY PLC
 to whose relevant securities the
 disclosure relates:

 

2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

 Class of    Product        Written or   Number of        Exercise   Type         Expiry
 relevant    description    purchased    securities to    price      e.g.         date
 security    e.g. call
which option    per unit   American,
             option
or derivative              European
                                         relates                     etc.
 Common      Call Option    Purchased    9,000            2.5 USD    American     20/03/2026

 Common      Call Option    Purchased    2,000            7.5 USD    American     20/03/2026

 Common      Put Option     Purchased    -80,700          2.5 USD    American     15/01/2027

 Common      Call Option    Purchased    1,000            5.0 USD    American     20/03/2026

 Common      Put Option     Purchased    -200             7.5 USD    American     15/08/2025

 Common      Put Option     Purchased    -4,800           2.5 USD    American     15/08/2025

 Common      Put Option     Purchased    -200             5.0 USD    American     19/09/2025

 Common      Put Option     Purchased    -3,100           2.5 USD    American     19/12/2025

 Common      Call Option    Purchased    14,600           5.0 USD    American     19/09/2025

 Common      Call Option    Purchased    400              2.5 USD    American     15/08/2025

 Common      Call Option    Purchased    10,300           2.5 USD    American     15/01/2027

 Common      Call Option    Purchased    800              5.0 USD    American     19/12/2025

 Common      Put Option     Purchased    -200             5.0 USD    American     15/08/2025

 Common      Put Option     Purchased    -7,200           2.5 USD    American     19/09/2025

 Common      Call Option    Sold         -14,400          5.0 USD    American     15/01/2027

 Common      Call Option    Sold         -200             7.5 USD    American     19/09/2025

 Common      Call Option    Sold         -17,200          2.5 USD    American     19/09/2025

 Common      Call Option    Sold         -5,000           2.5 USD    American     19/12/2025

 

3.             AGREEMENTS TO PURCHASE OR SELL

 

 Full details should be given so that the nature of the interest or position
 can be fully understood:

 

Ap33

 

4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING
DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

 

 Class of relevant security in relation to which subscription right exists:
 Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to
cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act,
1997, Takeover Rules, 2022.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ITPPKNBNBBKDAFD